These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28583565)

  • 1. Role of Urinary Neutrophil Gelatinase-Associated Lipocalin for Predicting the Severity of Renal Functions in Patients With Autosomal-Dominant Polycystic Kidney Disease.
    Vareesangthip K; Vareesangthip K; Limwongse C; Reesukumal K
    Transplant Proc; 2017 Jun; 49(5):950-954. PubMed ID: 28583565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophil gelatinase-associated lipocalin in patients with autosomal-dominant polycystic kidney disease.
    Bolignano D; Coppolino G; Campo S; Aloisi C; Nicocia G; Frisina N; Buemi M
    Am J Nephrol; 2007; 27(4):373-8. PubMed ID: 17570904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Genotype-phenotype correlation in ADPKD: a possible role for NGAL?].
    Virzì GM; Gastaldon F; Corradi V; de Cal M; Cruz DN; Clementi M; Ronco C
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24941494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.
    Parikh CR; Dahl NK; Chapman AB; Bost JE; Edelstein CL; Comer DM; Zeltner R; Tian X; Grantham JJ; Somlo S
    Kidney Int; 2012 Apr; 81(8):784-90. PubMed ID: 22258321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular secretion of creatinine in autosomal dominant polycystic kidney disease: consequences for cross-sectional and longitudinal performance of kidney function estimating equations.
    Spithoven EM; Meijer E; Boertien WE; Sinkeler SJ; Tent H; de Jong PE; Navis G; Gansevoort RT
    Am J Kidney Dis; 2013 Sep; 62(3):531-40. PubMed ID: 23714171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in tubular biomarkers with dietary intervention and metformin in patients with autosomal dominant polycystic kidney disease: a post-hoc analysis of two clinical trials.
    Wang W; You Z; Steele CN; Gitomer B; Chonchol M; Nowak KL
    BMC Nephrol; 2024 Jun; 25(1):206. PubMed ID: 38918734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary biomarkers at early ADPKD disease stage.
    Petzold K; Poster D; Krauer F; Spanaus K; Andreisek G; Nguyen-Kim TD; Pavik I; Ho TA; Serra AL; Rotar L
    PLoS One; 2015; 10(4):e0123555. PubMed ID: 25875363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring urinary biomarkers in autosomal dominant polycystic kidney disease.
    Kawano H; Muto S; Ohmoto Y; Iwata F; Fujiki H; Mori T; Yan L; Horie S
    Clin Exp Nephrol; 2015 Oct; 19(5):968-73. PubMed ID: 25543187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil gelatinase-associated lipocalin reflects the severity of renal impairment in subjects affected by chronic kidney disease.
    Bolignano D; Lacquaniti A; Coppolino G; Campo S; Arena A; Buemi M
    Kidney Blood Press Res; 2008; 31(4):255-8. PubMed ID: 18600028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary N-acetyl-β-D glucosaminidase as a surrogate marker for renal function in autosomal dominant polycystic kidney disease: 1 year prospective cohort study.
    Park HC; Hwang JH; Kang AY; Ro H; Kim MG; An JN; In Park J; Kim SH; Yang J; Oh YK; Oh KH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2012 Aug; 13():93. PubMed ID: 22935351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
    Damman K; van Veldhuisen DJ; Navis G; Voors AA; Hillege HL
    Eur J Heart Fail; 2008 Oct; 10(10):997-1000. PubMed ID: 18804416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of neutrophil gelatinase-associated lipocalin in the revised chronic kidney disease classification.
    Xiang D; Zhang H; Bai J; Ma J; Li M; Gao J; Wang C
    Int J Clin Exp Pathol; 2014; 7(10):7172-81. PubMed ID: 25400814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
    Nishida M; Kawakatsu H; Okumura Y; Hamaoka K
    Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fasting during the month of Ramadan on renal function in patients with autosomal dominant polycystic kidney disease
.
    Ekinci I; Erkoc R; Gursu M; Dogan EE; Kilic E; Cebeci E; Ozturk S; Kazancioglu R
    Clin Nephrol; 2018 Feb; 89(2):103-112. PubMed ID: 29035195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary neutrophil gelatinase-associated lipocalin and progression of diabetic nephropathy in type 1 diabetic patients in a four-year follow-up study.
    Nielsen SE; Hansen HP; Jensen BR; Parving HH; Rossing P
    Nephron Clin Pract; 2011; 118(2):c130-5. PubMed ID: 21160226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY
    Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
    Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.